Welcome to Marin Trading

October 7, 2011
By

Here you’ll find information that we hope will help you learn how to become a better trader.

Our focus is on technical analysis, which we feel offers timely guidance on entries, exits, profit targets, and risk management, as well as portfolio and equity curve analysis.   We also discuss the important issues of psychology in trading, such as loss aversion and confirmation bias.  Find out more about Dan here, as well as hear what some of our traders have to say.

Should you be interested in expanding your trading skills, we have a small group of traders that meet regularly with Dan to discuss current market conditions, and continue to develop their trading skills through Dan’s example and guidance. Read more »

The “Market Chainsaw” Effect

July 6, 2017
By

To make money (and not lose money) trading, you have to identify/avoid what I call the market chainsaw area(s), and move away in time-frame and/or style. This market to me seems like the chainsaw areas are really “swollen”…normal summer trading, and severe rotation in stocks; FANG, Oil, Financials, etc. “Chainsaw” areas shown as local maxima or “hills” below.

FANG Stocks Approaching Upper Channel

May 25, 2017
By

Going be interesting to watch the FANG stocks and the market as $AMZN/$GOOGL reach 1000 and FANG at upper channel….

$AUPH Breaking Out On Drug News

April 21, 2017
By

Relavent info-“Both doses of voclosporin at 48 weeks demonstrated continued improvement over the control group across multiple dimensions. Notably, the voclosporin groups demonstrated statistically significantly improved speed and rates of CR and PR. Of the patients that achieved CR at 24 weeks, in the low-dose voclosporin group, 100% remained in CR at 48 weeks, which demonstrates durability of clinical response. Proteinuria levels and reduction in SLEDAI scores, which include non-renal measures of lupus activity, also continued to significantly separate over time versus the control group. Additional analyses are ongoing and will be presented at future medical and scientific meetings. No unexpected safety signals were observed and voclosporin was generally well-tolerated, with the nature of adverse events consistent with what is expected of patients suffering from highly active LN while undergoing immunomodulation-based therapy.”

$NUE at support

April 18, 2017
By

$NUE at int. term support: Previous Low, Previous High, 200ma, 50% ret., also lower BB Daily and Weekly.

Note: Earnings Thursday  4/20 before the open.

 

 

$WFC great r/r under 52

April 13, 2017
By

50% retracement, 200ma, very oversold short and int. term:

$AMGN 200ma setup

April 10, 2017
By

Looking at $AMGN after gap fill, basing on 200ma. Earn 4/26:

 

Quick Reference Videos

Click on links below for an Introduction to Dan's Mentoring Group and a Recent Advance Class Meeting -

btm022613

btm021213b

bmt2_8